RxDoctor Payments Data

Abdul Mohammed, MD

Rheumatology · Chicago, ILNPI 1790102804

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 0th percentile of 287 rheumatology providers in Illinois.

See all rheumatology providers in Illinois

Medicare billing

Part B allowed, 2024
$1,156,412
Medicare patients
409
Services billed
75,892

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab93$646,555
Enbrel SureclickEtanercept69$587,327
Humira PenAdalimumab17$152,514
SimponiGolimumab24$145,544
EnbrelEtanercept19$135,396
RinvoqUpadacitinib18$121,371
KevzaraSarilumab27$119,058
XeljanzTofacitinib Citrate15$85,146
ForteoTeriparatide12$50,400
TymlosAbaloparatide13$32,591
Hydroxychloroquine Sulfate233$7,146
MethotrexateMethotrexate Sodium277$7,040
Leflunomide71$5,052
Prednisone357$3,277
Mycophenolate Mofetil28$2,943

Paid to pharmacies, not to this prescriber.

Other rheumatology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →